News

The partner has received an exclusive option to obtain U.S. commercial rights to SST’s topical ibuprofen (SST-0225) upon its approval by the U.S. FDA. SST-0225 is a patented

Erwinaze is specified as an element of a multi-agent chemotherapeutic regimen to treat patients suffering from acute lymphoblasticleukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase. Jazz

Kalon is a biopharmaceutical contract manufacturing organization with advanced technologies and facilities. It is a key subcontractor to one of the three Centers for Innovation in Advanced Development

An agreement to this effect was signed between both the companies. As per the agreed terms, Cardinal Health will build a 64,000ft2 facility in Indianapolis for the production

With the acquisition, UPS will be able to strengthen its healthcare expertise and network in Europe and enable compliant logistics services to customers to help them stream their

Launched after the completion of the iv clinical development programme, posaconazole concentrate for solution for iv provides another option for treatment of fungal infections in critically ill patients

The acquisition of the over-the-counter nicotine replacement therapy transdermal patch was completed last month following issuance of the proposed consent order from the US Federal Trade Commission (FTC).

Velcade covers use of bortezomib along with rituximab, cyclophosphamide, doxorubicin and prednisone for the treatment of adult patients with previously untreated MCL, who are unsuitable for haematopoietic stem

Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010 (due to increased risk of seizures, heart attacks, arrhythmia and strokes). Phenolphthalein is